"High dose chemotherapy" trang 1 - tải miễn phí từ tailieunhanh
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma - a randomized phase III trial (MATRix)

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma - a randomized phase III trial (MATRix)
9    63    1
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMACNS trial

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMACNS trial
10    1    1
High dose chemotherapy and autologous hematopoietic stem cell rescue for children with high risk neuroblastoma: Two case report

High dose chemotherapy and autologous hematopoietic stem cell rescue for children with high risk neuroblastoma: Two case report
5    58    3
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients
7    63    1
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: A retrospective, multicenter cohort study

First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: A retrospective, multicenter cohort study
10    1    1
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting

High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
10    95    1
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: Factors influencing clinical implementation

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: Factors influencing clinical implementation
11    8    1
Outcome and prospective factor analysis of high-dose therapy combined with autologous peripheral blood stem cell transplantation in patients with peripheral T-cell lymphomas

Outcome and prospective factor analysis of high-dose therapy combined with autologous peripheral blood stem cell transplantation in patients with peripheral T-cell lymphomas
8    109    0
The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: An ambispective cohort study

The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: An ambispective cohort study
9    19    1
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution

Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution
11    87    0
Báo cáo khoa học:

Báo cáo khoa học: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer"
10    77    0
Rationale and design of the Germanspeaking myeloma multicenter group (GMMG) trial HD6: A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

Rationale and design of the Germanspeaking myeloma multicenter group (GMMG) trial HD6: A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
11    95    0
Optimizing MATRix as remission induction in PCNSL: De-escalated induction treatment in newly diagnosed primary CNS lymphoma

Optimizing MATRix as remission induction in PCNSL: De-escalated induction treatment in newly diagnosed primary CNS lymphoma
9    2    1